Large-scale testing of women in Copenhagen has not reduced the prevalence of Chlamydia trachomatis infections

Clinical Microbiology and Infection

Volumn 9, Issue 7, 2003, Pages 619-624

  Westh, Henrik ^a   Kolmos, H J ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Chlamydia trachomatis; Epidemiology; Methods; Screening; Sensitivity; Specificity; STI

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DENMARK; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; GENOME ANALYSIS; GROUPS BY AGE; HUMAN; MEDICAL DECISION MAKING; MEDICAL EXAMINATION; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

CHLAMYDIA TRACHOMATIS;

EID: 0042527373     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00554.x     Document Type: Article

References (16)

1. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden. Sex Transm Dis 1996; 23: 384-91.
2. Scholes D, Stergachis A, Heidrich FE et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-6.
3. Egger M, Low N, Smith GD et al. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316: 1776-80.
4. Mangione-Smith R, O'Leary J, McGlynn EA. Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis 1999; 26: 309-16.
5. Genc M, Mardh A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124: 1-7.
6. Duncan B, Hart G. Sexuality and health: the hidden costs of screening for Chlamydia trachomatis. BMJ 1999; 318: 931-3.
7. Anonymous. Chlamydia trachomatis genital infections - United States, 1995. MMWR 1997; 46: 193-8.
8. Vincelette J, Schirm J, Bogard M et al. Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1999; 37: 74-80.
9. Van Der Pol B, Quinn TC, Gaydos CA et al. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol 2000; 38: 1105-12.
10. Doing KM, Curtis K, Long JW, Volock ML. Prospective comparison of the General-probe PACE 2 assay and the Abbott ligase chain reaction for the direct detection of Chlamydia trachomatis in a low prevalence population. J Med Microbiol 1999; 48: 507-10.
11. Puolakkainen M, Hiltunen-Back E, Reunala T et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998; 36: 1489-93.
12. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10: 160-84.
13. Groseclose SL, Zaidi AA, DeLisle SJ, Levine WC, St Louis ME. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999; 26: 339-44.
14. Kamwendo F, Forslin L, Bodin L, Danielsson D. Programmes to reduce pelvic inflammatory disease - the Swedish experience. Lancet 1998; 351(suppl 3): 25-28.
15. Andersen B, Ostergaard L, Moller JK, Olesen F. Effectiveness of a mass media campaign to recruit young adults for testing of Chlamydia trachomatis by use of home obtained and mailed samples. Sex Transm Infect 2001; 77: 416-18.
16. Marrazzo JM, Celum CL, Hillis SD et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis 1997; 24: 131-41.